Article

Therapeutic Monoclonal Antibodies Repurposing in Oncology via IMGT/mAb-KG Embeddings

2025-09-10

Abstract excerpt

<h4>Background</h4> Cancer remains one of the leading causes of mortality world-wide, accounting for approximately 9.7 million deaths in 2022. Faced with this significant public health challenge, therapeutic monoclonal antibodies (mAbs) have emerged as promising alternatives that may minimize the side effects associated with conventional treatments such as radiotherapy and chemotherapy. To support mAb research an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 68b76bc8-3700-59d8-a7ca-ecfe1c099ad3
DOI: 10.1101/2025.09.05.674444

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Therapeutic Monoclonal Antibodies Repurposing in Oncology via IMGT/mAb-KG EmbeddingsDOI 10.1101/2025.09.05.674444Read

Artemis: Harnessing Knowledge Graphs for Next-Generation Drug Target PrioritizationSemantic proximity Read

A patient-centric knowledge graph approach to prioritize mutants for selective anti-cancer targetingSemantic proximity Read

Using Graph-Based Signatures to Guide Rational Antibody Engineering.Semantic proximity Read

immuneKG: An Immune-Cell-Aware Knowledge Graph Framework for Target Discovery in Immune-Mediated DiseasesSemantic proximity Read

Integrating knowledge graphs into machine learning models for survival prediction and biomarker discovery in patients with non-small-cell lung cancer.Semantic proximity Read

A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare DiseasesSemantic proximity Read

CellAwareGNN: Single-Cell Enhanced Knowledge Graph Foundation Model for Drug Indication PredictionSemantic proximity Read

Finding melanoma drugs through a probabilistic knowledge graphSemantic proximity Read

The Virtual Biotech: A Multi-Agent AI Framework for Therapeutic Discovery and DevelopmentSemantic proximity Read

Immunotherapy drug target identification using machine learning and patient-derived tumour explant validationSemantic proximity Read

Integrating Knowledge Graphs into Machine Learning Models for Survival Prediction and Biomarker Discovery in Patients with Non–Small-Cell Lung CancerSemantic proximity Read

AI-based Cancer Models for Prediction of Antibody-Drug Conjugate (ADC) Response in OncologySemantic proximity Read